We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Next Gen Human Gut Microbiome Tests Enable Comprehensive Gastrointestinal Testing

By LabMedica International staff writers
Posted on 14 Mar 2023
Print article
Image: The MetaXplore human gut microbiome testing product range has been launched in Australia (Photo courtesy of Microba Life Sciences)
Image: The MetaXplore human gut microbiome testing product range has been launched in Australia (Photo courtesy of Microba Life Sciences)

A new range of next-generation human gut microbiome tests provides diagnostic gastrointestinal health testing along with metagenomic gut microbiome analysis.

Microba Life Sciences Limited (Brisbane, Australia) has launched its next-generation testing product range, MetaXplore to healthcare professionals in Australia under a new brand, Co-Biome. The new MetaXplore range provides diagnostic gastrointestinal health testing along with metagenomic-driven gut microbiome analysis to deliver comprehensive gastrointestinal testing solutions for healthcare professionals. The range consists of three products MetaXplore, MetaXplore GI, and MetaXplore GI Plus.

The tests are intended for the detection of diagnostic and investigative gastrointestinal health markers (fecal calprotectin, fecal occult blood, lactoferrin, pancreatic elastase, secretory IgA, Zonulin, Fecal pH), along with diagnostic pathogens and parasites (E.coli pathotypes, C.difficile pathotypes, Campylobacter spp., Yersinia enterocolitica, Vibrio spp., Aeromonas spp., Salmonella spp., Giardia lamblia, Entamoeba histolytica, Cryptosporidium spp., Dientamoeba fragilis, Cyclospora cayetanensis). The tests provide complete microbiome profiling (microbial diversity, richness, and profiling of over 28,000+ microbial species including bacteria, fungi, parasite, and archaea detection, along with parasite detection of Blastocystis subtypes 1-9 and other eukaryotes). The results are available in an easy-to-interpret report format that is designed to aid efficient patient consultation for healthcare professionals.

“The new MetaXplore test range delivers an important advancement in how microbiome test information can be applied in a healthcare setting,” said Dr. Luke Reid, Microba’s Chief Executive Officer. “We continue to make progress at the forefront of this field to advance the application of microbiome testing in a healthcare setting towards a future where it can be routine in health and disease management, much like a blood test is today.”

“These new tests integrate traditional gastrointestinal pathology tools with Microba’s next-generation microbiome testing technology and the latest global research to significantly advance the utility of microbiome testing in a healthcare setting. This test range is expected to significantly expand the total addressable market for Microba’s testing products,” added Assoc Prof. Lutz Krause, Microba’s Chief Scientific Officer.

Related Links:
Microba Life Sciences Limited 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.